CLYM (Climb Bio) Dividends Received


CLYM Climb Bio Inc CLYM
22 GF Score
Price $13.81
! 3 Warning Signs
View Full Analysis

What is Climb Bio Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

CLYM
22GF Score
Climb Bio Inc CLYM
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Climb Bio Business Description

Address 20 William Street, Suite 145, Wellesley Hills, MA, USA, 02481
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
22GF Score

Get the complete analysis for CLYM

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.81
Price